Edward N. and Della L. Thome Memorial Foundation, Bank of America, N.A., Trustee, Awards Program in Alzheimer's Disease Drug Discovery Research

The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults. In keeping with the Foundation’s mission, we are pleased to announce the 2012 Awards Program in Alzheimer’s Disease Drug Discovery Research. The goal of the 2012 Awards Program is to support pilot studies towards innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer’s disease.

As steward of the Thome Memorial Foundation, Bank of America, N.A. works with the Scientific Review Committee selected by The Medical Foundation division, to decide on the most qualified candidates. The 2012 Awards Program supports pilot studies in preclinical development and design of novel small molecules and compounds for the therapeutic control of validated targets in Alzheimer’s disease. Consideration will be given to research based on the amyloid hypothesis and alternative pathogenic mechanisms. Genetic studies, biomarker research, neuro-imaging, clinical studies, basic research and new target discovery are currently outside the scope of this Program.

All applicants must hold a faculty appointment at a non-profit academic, medical, non-governmental or research institution in the United States. US citizenship is not required. Applicants do not need to be nominated by their institutions. Preference will be given to originality of ideas, regardless of faculty seniority.

Further details regarding eligibility requirements may be found in the "Application Guidelines and Instructions" document.